Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine Research|May 5, 2025
Lipoprotein(a)-Lowering Drugs: A Mini ReviewMasato Hamasaki, Kazuhiko Kotani
Cardiology Research|November 23, 2020
Lipoprotein(a) and Familial Hypercholesterolemia: A Short Review Including the Laboratory ViewpointMasato Hamasaki, Kazuhiko Kotani
Acta Bio-Medica : Atenei Parmensis|December 19, 2022
γGT and PCSK9 variants in subjects with hyper-LDL-cholesterolemiaKazuhiko Kotani, Masato Hamasaki, Snehal Kapse
Journal of Clinical Medicine|March 6, 2021
The Effect of <i>Helicobacter pylori</i> Eradication on Lipid Levels: A Meta-AnalysisJun Watanabe, Masato Hamasaki, Kazuhiko Kotani
Archives of Medical Sciences. Atherosclerotic Diseases|August 25, 2020
Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a reviewJun Watanabe, Masato Hamasaki, Kazuhiko Kotani
Journal of Clinical Laboratory Analysis|October 15, 2021
LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapyMasato Hamasaki, Naoki Sakane, Kazuo Hara, et al.
Molecular Nutrition & Food Research|May 8, 2026
High-Density Lipoprotein-Specific Phospholipid Efflux (HDL-SPE) Assay in MiceMasaki Sato, Edward B Neufeld, Masato Hamasaki, et al.
Annals of Clinical and Laboratory Science|July 24, 2024
<i>Communication:</i> High-Density Lipoprotein-Specific Phospholipid Efflux in Familial HypercholesterolemiaMasaki Sato, Masato Hamasaki, Edward B Neufeld, et al.
Journal of Biochemistry|July 9, 2015
Functional implication of archaeal homologues of human RNase P protein pair Pop5 and Rpp30Masato Hamasaki, Kohsuke Hazeyama, Fumihiko Iwasaki, et al.
Pageof 2